These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 1693780

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Antinociceptive and substance P antagonistic effects of intrathecally injected spantide II in rat: no signs of motor impairment or neurotoxicity.
    Wiesenfeld-Hallin Z, Xu XJ, Kristensson K, Håkanson R, Feng DM, Folkers K.
    Regul Pept; 1990 Jun; 29(1):1-11. PubMed ID: 1697080
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Stability and degradation profiles of Spantide II in aqueous solutions.
    Kikwai L, Babu RJ, Kanikkannan N, Singh M.
    Eur J Pharm Sci; 2006 Feb; 27(2-3):158-66. PubMed ID: 16266798
    [Abstract] [Full Text] [Related]

  • 28. Activity of spantide I and II at various tachykinin receptors and NK-2 tachykinin receptor subtypes.
    Maggi CA, Patacchini R, Feng DM, Folkers K.
    Eur J Pharmacol; 1991 Jun 18; 199(1):127-9. PubMed ID: 1716573
    [Abstract] [Full Text] [Related]

  • 29. Reduced peptide bond pseudopeptide analogues of substance P. A new class of substance P receptor antagonists with enhanced specificity.
    Qian JM, Coy DH, Jiang NY, Gardner JD, Jensen RT.
    J Biol Chem; 1989 Oct 05; 264(28):16667-71. PubMed ID: 2476445
    [Abstract] [Full Text] [Related]

  • 30. Influence of the replacement of amino acid by its D-enantiomer in the sequence of substance P. 2. Conformational analysis by NMR and energy calculations.
    Convert O, Duplaa H, Lavielle S, Chassaing G.
    Neuropeptides; 1991 Aug 05; 19(4):259-70. PubMed ID: 1717877
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The specific antagonistic effect of intrathecal spantide II on substance P- and C-fiber conditioning stimulation-induced facilitation of the nociceptive flexor reflex in rat.
    Wiesenfeld-Hallin Z, Xu XJ, Håkanson R, Feng DM, Folkers K.
    Brain Res; 1990 Sep 03; 526(2):284-90. PubMed ID: 1701683
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effects of spantide on guinea pig coronary resistance vessels.
    Hoover DB.
    Peptides; 1991 Sep 03; 12(5):983-8. PubMed ID: 1724800
    [Abstract] [Full Text] [Related]

  • 36. Vasoconstrictor effects in spinal cord of the substance P antagonist [D-Arg, D-Trp7,9 Leu11]-substance P (Spantide) and somatostatin and interaction with thyrotropin releasing hormone.
    Freedman J, Post C, Kåhrström J, Ohlen A, Mollenholt P, Owman C, Alari L, Hökfelt T.
    Neuroscience; 1988 Oct 03; 27(1):267-78. PubMed ID: 2462190
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Excitatory effect of substance P in parasympathetic ganglia of cat urinary bladder.
    Kawatani M, Whitney T, Booth AM, de Groat WC.
    Am J Physiol; 1989 Dec 03; 257(6 Pt 2):R1450-6. PubMed ID: 2481406
    [Abstract] [Full Text] [Related]

  • 39. Tachykinin antagonists have potent local anaesthetic actions.
    Post C, Butterworth JF, Strichartz GR, Karlsson JA, Persson CG.
    Eur J Pharmacol; 1985 Nov 19; 117(3):347-54. PubMed ID: 2416579
    [Abstract] [Full Text] [Related]

  • 40. Characterization of ability of various substance P antagonists to inhibit action of bombesin.
    Jensen RT, Heinz-Erian P, Mantey S, Jones SW, Gardner JD.
    Am J Physiol; 1988 Jun 19; 254(6 Pt 1):G883-90. PubMed ID: 2454035
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.